Use of artificial intelligence in healthcare - opportunities, support, implementation, ethics, safeguarding, data, and engagement with clinicians and patients

  • Thursday, 27 May 2021, 8:30 AM to 1:00 PM

This session will focus on the future of artificial intelligence within healthcare.

Delegates will discuss the potential applications of AI in improving diagnosis and care, as well as measures that can be taken to support research, development, and implementation - along with priorities for addressing issues in areas such as ethics, bias and use of data.

It is taking place in the context of COVID-19, which has seen a rise in the use of AI as part of the healthcare response to the pandemic, and the ongoing AAC/NHSX/NIHR AI in Health and Care Award.

Areas for discussion include:

·         the potential of artificial intelligence within healthcare and progress in its application so far

·         ethical considerations and lessons from other sectors

·         data sharing and security concerns

·         avoiding bias, developing safeguards, and the priorities for skills and diversity in the sector

·         priorities for supporting research and development, and for overcoming barriers to implementation

The discussion is bringing together stakeholders with key policy officials who are due to attend from DHSC; the MHRA; DCMS; DIT; and the Scottish Government.

Keynote contributions: Dr Indra Joshi, Director of AI, NHSX; Dr Nicole Mather, Non-Executive Director, Health Research Authority and Executive Partner, IBM; Dr Nathalie Moreno, Partner, Addleshaw Goddard; Johan Ordish, Deputy Director, Medical Device Software and Digital Health, Medicines and Healthcare Products Regulatory Agency; and Professor Carola Bibiane Schönlieb, Professor of Applied Mathematics and Head, Cambridge Image Analysis Group, Department of Applied Mathematics and Theoretical Physics, University of Cambridge.

Speakers also confirmed: Dr Janet Allen, Senior Research Associate in Digital Health, University of Cambridge and formerly Director of Strategic Innovation, Cystic Fibrosis Trust; Professor Alastair Denniston, Consultant Ophthalmologist, Research and Innovation, University Hospitals Birmingham NHSFT; Deputy Director, Birmingham Health Partners Centre for Regulatory Science and Innovation; and Member, Regulatory Horizons Council (UK); Professor Mark Halling-Brown, Head of Scientific Computing, Royal Surrey County Hospital; and Dr Darren Treanor, Chair, Royal College of Pathologists Digital Pathology Committee and Consultant Pathologist, Leeds Teaching Hospital NHS Trust.

Options and charges are as follows:

  • Access to Use of artificial intelligence in healthcare - opportunities, support, implementation, ethics, safeguarding, data, and engagement with clinicians and patients (plus a permanent record of proceedings) is £190 plus VAT per delegate;
  • Concessionary rate places for small charities, unfunded individuals and those in similar circumstances are £85 plus VAT. Please be sure to apply for this at the time of booking.

Find out more from WHF

Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.

Learn more

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.